Results 111 to 120 of about 12,043,843 (293)

SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI

open access: yesESC Heart Failure, EarlyView.
Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra   +25 more
wiley   +1 more source

Advancing cardio‐obstetric care through digital health technologies: A narrative review

open access: yesESC Heart Failure, EarlyView.
Telehealth has enhanced prenatal and post‐partum care by improving access, continuity, and equity, particularly for high‐risk and underserved populations, without compromising maternal or fetal outcomes. Wearable and digital health technologies (e.g., electrocardiogram sensors, remote BP monitoring, mobile interventions) show strong potential to ...
Toluwalase Awoyemi   +11 more
wiley   +1 more source

Use of artificial intelligence for detecting left ventricular dysfunction and predicting incident heart failure risk

open access: yesESC Heart Failure, EarlyView.
Abstract Effective medications are available for the prevention of heart failure (HF). While their use is indicated in patients with risk factors, engagement and adherence among ‘at risk’ individuals is challenging, as it is with atherosclerotic heart disease prevention.
Anna Węgrzyn‐Witek   +3 more
wiley   +1 more source

Genome‐wide meta‐analysis of SNP and antihypertensive medication interactions on left ventricular traits in African Americans

open access: yesMolecular Genetics & Genomic Medicine, 2019
Background Left ventricular (LV) hypertrophy affects up to 43% of African Americans (AAs). Antihypertensive treatment reduces LV mass (LVM). However, interindividual variation in LV traits in response to antihypertensive treatments exists.
Anh N. Do   +24 more
doaj   +1 more source

Cardioimmunologic response patterns after an acute heart failure event: Design and first results of AHF‐ImmunoCS

open access: yesESC Heart Failure, EarlyView.
Abstract Aims We have previously shown that patients who develop heart‐reactive antibodies (HRAs) de novo after a heart failure (HF) hospitalization are at increased risk of adverse outcomes, lending weight to the hypothesis that B cells may play a pivotal role in HF progression.
Niklas Beyersdorf   +19 more
wiley   +1 more source

Therapy gaps for patients with heart failure and reduced kidney function: A prospective cohort study

open access: yesESC Heart Failure, EarlyView.
In this prospective registry of 1401 heart failure outpatients, patients with eGFR <60 mL/min/1.73m2 had lower achievement of target RASi and MRA doses, with the lowest absolute use in patients with eGFR <30. Beta blockers were consistently prescribed across all heart failure phenotypes and kidney function.
Chen Hsiang Ma   +12 more
wiley   +1 more source

INDIVIDUAL, ABSOLUTE AND RELATIVE CARDIOVASCULAR RISK IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION AND ITS DYNAMICS UNDER ANTIHYPERTENSIVE TREATMENT

open access: yesРоссийский кардиологический журнал, 2001
We have estimated the 10-year absolute (AR) and relative (RR) cardiovascular risk in 30 patients (12 men and 18 women, mean age 55,5±7,2 years with essential hypertension, mild to severe (WHO/ISH, 1999) with the usage of a computer program dealing with ...
B. A. Hapayev, L. I. Olbinskaya
doaj  

Evaluation of antihypertensive drugs use in a tertiary hospital setting – A cross-sectional study

open access: yesJournal of Dr. NTR University of Health Sciences
Background: Hypertension, a well-known risk factor for cardiovascular diseases, significantly impacts life expectancy. Managing antihypertensive medications effectively is critical in this context.
Madhavulu Buchineni   +7 more
doaj   +1 more source

Endothelial Function Is Impaired in Patients Receiving Antihypertensive Drug Treatment Regardless of Blood Pressure Level [PDF]

open access: bronze, 2017
Tatsuya Maruhashi   +44 more
openalex   +1 more source

Home - About - Disclaimer - Privacy